Double maintains 4 strategies that include TXG - 10X Genomics, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 62.81% | $977.87M | 0.75% |
GNOM | 57.28% | $53.29M | 0.5% |
ARKK | 50.52% | $5.08B | 0.75% |
KOMP | 49.82% | $1.95B | 0.2% |
MOAT | 49.80% | $13.43B | 0.47% |
SMOT | 49.80% | $412.48M | 0.49% |
IBUY | 49.78% | $153.92M | 0.65% |
VBK | 49.74% | $17.51B | 0.07% |
NUSC | 49.65% | $1.11B | 0.31% |
IWO | 49.61% | $10.88B | 0.24% |
SCHA | 49.45% | $15.95B | 0.04% |
XHE | 48.92% | $174.25M | 0.35% |
ISCG | 48.89% | $654.50M | 0.06% |
PBW | 48.78% | $215.57M | 0.65% |
IWM | 48.77% | $64.21B | 0.19% |
VB | 48.77% | $59.15B | 0.05% |
ESML | 48.69% | $1.76B | 0.17% |
XRT | 48.66% | $226.26M | 0.35% |
VTWO | 48.60% | $10.91B | 0.07% |
QQQJ | 48.51% | $594.32M | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -37.36% | $404.97M | 1.43% |
VIXY | -28.49% | $195.31M | 0.85% |
TAIL | -26.49% | $86.92M | 0.59% |
USDU | -24.47% | $213.46M | 0.5% |
UUP | -23.54% | $327.80M | 0.77% |
CTA | -18.97% | $963.19M | 0.76% |
IVOL | -14.20% | $479.06M | 1.02% |
XONE | -11.18% | $628.76M | 0.03% |
STPZ | -10.66% | $443.63M | 0.2% |
DBE | -9.34% | $54.58M | 0.77% |
VTIP | -9.15% | $13.61B | 0.03% |
UGA | -8.68% | $88.11M | 0.97% |
TPMN | -8.11% | $33.51M | 0.65% |
BUXX | -7.81% | $231.44M | 0.25% |
BSMR | -6.58% | $232.31M | 0.18% |
BNO | -6.48% | $95.40M | 1% |
ULST | -6.39% | $587.03M | 0.2% |
USO | -5.40% | $1.02B | 0.6% |
USCI | -5.40% | $236.09M | 1.07% |
OILK | -5.26% | $66.42M | 0.69% |
Yahoo
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
SeekingAlpha
Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential and FY 2025 outlook.
Yahoo
The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research.
Yahoo
What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many shareholders. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Finnhub
SEATTLE - Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercode single cell...
Yahoo
10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the United States District Court for the District of Delaware, Parse agreed - a week before trial was to start - to a worldwide permanent injunction that prevents it from making, using, selling or offering for sale its planned ATAC and ATAC-Multiome Single Cell products. As part of this cons
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ICLO | -0.13% | $354.53M | 0.2% |
SHY | 0.19% | $22.84B | 0.15% |
FTSM | 0.21% | $6.39B | 0.45% |
DBA | -0.25% | $822.16M | 0.93% |
KMLM | -0.36% | $222.40M | 0.9% |
VNLA | -0.54% | $2.55B | 0.23% |
FTSD | 0.57% | $220.28M | 0.25% |
XHLF | 0.63% | $1.06B | 0.03% |
TDTF | -0.63% | $806.58M | 0.18% |
CLOI | -0.70% | $1.02B | 0.4% |
USTB | 0.77% | $1.14B | 0.35% |
CLOA | 0.79% | $786.72M | 0.2% |
GSY | -0.86% | $2.82B | 0.23% |
TIPX | -0.87% | $1.65B | 0.15% |
AGZ | 0.92% | $644.74M | 0.2% |
FLRT | 0.95% | $514.26M | 0.6% |
FTGC | 1.14% | $2.50B | 1.02% |
SCHP | 1.22% | $12.96B | 0.03% |
IBTJ | 1.24% | $634.94M | 0.07% |
DBC | -1.32% | $1.32B | 0.87% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PACB | 55.15% | $351.47M | -67.67% | 0.00% |
BEAM | 49.20% | $1.95B | -40.20% | 0.00% |
SITE | 46.99% | $5.46B | -30.13% | 0.00% |
SDGR | 46.06% | $1.44B | -25.03% | 0.00% |
OPEN | 45.95% | $737.99M | -64.95% | 0.00% |
CRSP | 45.48% | $2.92B | -50.09% | 0.00% |
RXRX | 45.47% | $2.13B | -43.54% | 0.00% |
BLFS | 45.15% | $1.07B | +27.60% | 0.00% |
LAB | 44.65% | $409.30M | -60.00% | 0.00% |
POWI | 44.53% | $2.87B | -28.54% | 1.55% |
RVTY | 44.46% | $12.71B | +2.45% | 0.26% |
RGEN | 44.36% | $7.14B | -30.45% | 0.00% |
FLGT | 44.23% | $521.63M | -22.55% | 0.00% |
CERS | 44.01% | $258.25M | -22.78% | 0.00% |
AZTA | 43.97% | $1.58B | -41.33% | 0.00% |
ADPT | 43.77% | $1.10B | +138.91% | 0.00% |
CRBU | 43.73% | $84.92M | -81.92% | 0.00% |
MBC | 43.33% | $1.67B | -28.94% | 0.00% |
BXC | 43.08% | $621.95M | -41.45% | 0.00% |
BRKR | 42.92% | $6.33B | -55.08% | 0.48% |
Current Value
$8.671 Year Return
Current Value
$8.671 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BNED | 0.04% | $357.56M | -83.95% | 0.00% |
MPC | 0.08% | $45.39B | -28.73% | 2.37% |
LNG | -0.11% | $51.76B | +45.23% | 0.81% |
BP | -0.13% | $89.11B | -10.94% | 5.60% |
KNOP | -0.14% | $239.40M | +36.86% | 1.44% |
PNW | 0.16% | $11.36B | +28.63% | 3.73% |
NOC | -0.19% | $74.12B | +8.63% | 1.60% |
GEL | -0.25% | $1.92B | +38.24% | 4.02% |
AVDL | -0.27% | $756.61M | -53.00% | 0.00% |
NEUE | -0.29% | $58.51M | +7.28% | 0.00% |
OXBR | -0.30% | $14.07M | +68.75% | 0.00% |
PPC | 0.31% | $12.93B | +57.95% | 0.00% |
EE | -0.31% | $684.58M | +80.83% | 0.63% |
API | -0.32% | $293.58M | +57.65% | 0.00% |
TXMD | 0.42% | $10.67M | -60.13% | 0.00% |
AFL | 0.47% | $60.69B | +30.52% | 1.88% |
CVX | -0.56% | $292.71B | +5.16% | 3.95% |
SU | 0.61% | $47.90B | +3.78% | 4.15% |
SAFT | 0.66% | $1.17B | -2.70% | 4.56% |
HESM | 0.69% | $4.94B | +17.64% | 6.43% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -24.39% | $23.69B | +24.42% | 1.08% |
MCK | -14.05% | $84.34B | +25.44% | 0.41% |
PGR | -12.51% | $165.90B | +34.80% | 1.73% |
T | -11.28% | $203.00B | +61.60% | 3.91% |
ALL | -10.94% | $54.88B | +19.99% | 1.81% |
CQP | -10.80% | $31.97B | +33.68% | 4.87% |
DUK | -10.59% | $94.77B | +26.96% | 3.42% |
K | -10.50% | $28.48B | +44.57% | 2.75% |
PULM | -10.20% | $24.32M | +282.76% | 0.00% |
KMB | -9.93% | $47.17B | +10.42% | 3.45% |
FATBB | -9.76% | $48.04M | -31.13% | 15.56% |
HIHO | -9.19% | $8.12M | -11.51% | 6.50% |
ED | -8.90% | $39.05B | +22.43% | 3.04% |
DAO | -8.84% | $238.29M | +83.86% | 0.00% |
CME | -8.50% | $95.61B | +25.13% | 3.98% |
MO | -8.26% | $101.47B | +38.87% | 6.74% |
TMUS | -8.21% | $304.51B | +63.96% | 1.15% |
VIRT | -8.13% | $3.30B | +81.18% | 2.53% |
CB | -7.19% | $120.92B | +17.32% | 1.20% |
SRDX | -7.07% | $436.46M | +9.43% | 0.00% |